{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:34:05Z","timestamp":1773380045720,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T00:00:00Z","timestamp":1345766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1748-717x-7-143","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T06:14:30Z","timestamp":1345788870000},"source":"Crossref","is-referenced-by-count":27,"title":["Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma"],"prefix":"10.1186","volume":"7","author":[{"given":"Piernicola","family":"Pedicini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Strigari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Alicia Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Alterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Cremonesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Botta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Vischioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocchina","family":"Caivano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Improta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Storto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Benassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,24]]},"reference":[{"key":"697_CR1","first-page":"313","volume":"25","author":"J Overgaard","year":"2000","unstructured":"Overgaard J, Alsner J, Eriksen J, et al.: Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. Rays 2000, 25: 313-319.","journal-title":"Rays"},{"key":"697_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","volume":"362","author":"J Overgaard","year":"2003","unstructured":"Overgaard J, Hansen HS, Specht L, et al.: Five compared with six fractions per week of conventional radiotherapy of squamous cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003, 362: 933-940. 10.1016\/S0140-6736(03)14361-9","journal-title":"Lancet"},{"key":"697_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0167-8140(97)01904-X","volume":"43","author":"O Hansen","year":"1997","unstructured":"Hansen O, Overgaard J, Hansen HS, et al.: Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumour differentiation. Radioth Oncol 1997, 43: 47-51. 10.1016\/S0167-8140(97)01904-X","journal-title":"Radioth Oncol"},{"key":"697_CR4","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1200\/JCO.1993.11.10.1873","volume":"11","author":"O Dassonville","year":"1993","unstructured":"Dassonville O, Forment JL, Francoual M, et al.: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 1993, 11: 1873-1878.","journal-title":"J Clin Oncol"},{"key":"697_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ijrobp.2003.09.043","volume":"58","author":"JG Eriksen","year":"2004","unstructured":"Eriksen JG, Steiniche T, Askaa J, et al.: The prognostic value of epidermal growth factor receptor is related to tumour differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Rad Onc Bio Phys 2004, 58: 561-566. 10.1016\/j.ijrobp.2003.09.043","journal-title":"Int J Rad Onc Bio Phys"},{"key":"697_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/02841860510007396","volume":"44","author":"JG Eriksen","year":"2005","unstructured":"Eriksen JG, Steiniche T, Overgaard J, et al.: The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma. Octa Oncol 2005, 44: 50-58. 10.1080\/02841860510007396","journal-title":"Octa Oncol"},{"key":"697_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.radonc.2005.05.004","volume":"76","author":"JG Eriksen","year":"2005","unstructured":"Eriksen JG, Alsner J, Steinich T, et al.: The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times. Radioth Oncol 2005, 76: 135-142. 10.1016\/j.radonc.2005.05.004","journal-title":"Radioth Oncol"},{"key":"697_CR8","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1200\/JCO.2005.06.411","volume":"23","author":"SM Bentzen","year":"2005","unstructured":"Bentzen SM, Atasoy BM, Daley FM, et al.: Epidermal Growth Factor Receptor Expression in Pretreatment Biopsies From Head and Neck Squamous Cell Carcinoma As a Predictive Factor for a Benefit From Accelerated Radiation Therapy in a Randomized Controlled Trial. J Clin Oncol 2005, 23: 5560-5567. 10.1200\/JCO.2005.06.411","journal-title":"J Clin Oncol"},{"key":"697_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ijrobp.2009.05.021","volume":"77","author":"R Suwinski","year":"2010","unstructured":"Suwinski R, Jaworska M, Nikiel B, et al.: Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial. Int J Rad Onc Bio Phys 2010, 77: 438-446. 10.1016\/j.ijrobp.2009.05.021","journal-title":"Int J Rad Onc Bio Phys"},{"key":"697_CR10","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.ijrobp.2006.03.011","volume":"65","author":"EJ Smid","year":"2006","unstructured":"Smid EJ, Stoter TR, Bloemena E, et al.: The importance of immunohistochemical expression of egfr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. Int J Rad Onc Bio Phys 2006, 65: 1323-1329. 10.1016\/j.ijrobp.2006.03.011","journal-title":"Int J Rad Onc Bio Phys"},{"key":"697_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijrobp.2010.05.024","volume":"81","author":"CH Chung","year":"2011","unstructured":"Chung CH, Zhang Q, Hammond EM, et al.: Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma. Int J Rad Onc Bio Phys 2011, 81: 331-338. 10.1016\/j.ijrobp.2010.05.024","journal-title":"Int J Rad Onc Bio Phys"},{"key":"697_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0360-3016(00)00666-0","volume":"48","author":"WA Tom\u00e9","year":"2000","unstructured":"Tom\u00e9 WA, Fowler JF, et al.: Selective boosting of tumour subvolumes. Int J Rad Onc Bio Phys 2000, 48: 593-599. 10.1016\/S0360-3016(00)00666-0","journal-title":"Int J Rad Onc Bio Phys"},{"key":"697_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2307\/3577839","volume":"124","author":"SL Tucker","year":"1990","unstructured":"Tucker SL, Thames HD, Taylor JM: How well is the probability of tumour cure after fractionated irradiation described by poisson statistics? Radiat Res 1990, 124: 273-282. 10.2307\/3577839","journal-title":"Radiat Res"},{"key":"697_CR14","volume-title":"Growth Kinetics of Tumours","author":"GG Steel","year":"1977","unstructured":"Steel GG: Growth Kinetics of Tumours. Oxford: Clarendon-Press; 1977."},{"key":"697_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0167-8140(95)01567-Z","volume":"36","author":"GD Wilson","year":"1995","unstructured":"Wilson GD, Discheb S, Saundersb MI: Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radioth Oncol 1995, 36: 189-197. 10.1016\/0167-8140(95)01567-Z","journal-title":"Radioth Oncol"},{"key":"697_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/bjc.1992.183","volume":"65","author":"MH Bennett","year":"1992","unstructured":"Bennett MH, Wilson GD, Dische S, et al.: Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 1992, 65: 870-878. 10.1038\/bjc.1992.183","journal-title":"Br J Cancer"},{"key":"697_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0167-8140(90)90149-Q","volume":"19","author":"HD Thames","year":"1990","unstructured":"Thames HD, Bentzen SM, Turesson I, et al.: Time-dose factors in radiotherapy: a review of the human data. Radioth Oncol 1990, 19: 219-235. 10.1016\/0167-8140(90)90149-Q","journal-title":"Radioth Oncol"},{"key":"697_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling survival data-in medical research","author":"D Collett","year":"1994","unstructured":"Collett D: Modelling survival data-in medical research. London: Chapman and Hall; 1994:22-26."},{"key":"697_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/(SICI)1520-6823(1999)7:3<125::AID-ROI1>3.0.CO;2-W","volume":"7","author":"BD Smith","year":"1999","unstructured":"Smith BD, Haffty BG: Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat Oncol Investig 1999, 7: 125-144. 10.1002\/(SICI)1520-6823(1999)7:3<125::AID-ROI1>3.0.CO;2-W","journal-title":"Radiat Oncol Investig"},{"key":"697_CR20","doi-asserted-by":"publisher","first-page":"e697","DOI":"10.1016\/j.ijrobp.2012.02.004","volume":"83","author":"L Strigari","year":"2012","unstructured":"Strigari L, Pedicini P, D'Andrea M, Benassi M: A model for predicting Acute Mucosal Toxicity (AMT) in head and neck cancer patients undergoing radiotherapy with altered schedule. Int J Rad Onc Bio Phys 2012, 83: e697-e702. 10.1016\/j.ijrobp.2012.02.004","journal-title":"Int J Rad Onc Bio Phys"},{"key":"697_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00022744-199806000-00006","volume":"6","author":"SR Shi","year":"1998","unstructured":"Shi SR, Cote RJ, Chaiwun B, et al.: Standardization of immunohistochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections. Appl Immunohistochem 1998, 6: 89-96. 10.1097\/00022744-199806000-00006","journal-title":"Appl Immunohistochem"},{"key":"697_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clon.2006.09.008","volume":"19","author":"JF Fowler","year":"2007","unstructured":"Fowler JF: Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling. J Clin Oncol 2007, 19: 8-22. 10.1016\/j.clon.2006.09.008","journal-title":"J Clin Oncol"},{"key":"697_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0167-8140(91)90019-D","volume":"22","author":"SM Bentzen","year":"1991","unstructured":"Bentzen SM, Thames HD: Clinical evidence for tumour clonogen regeneration: interpretations of the data. Radioth Oncol 1991, 22: 161-166. 10.1016\/0167-8140(91)90019-D","journal-title":"Radioth Oncol"},{"key":"697_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/0360-3016(91)90228-V","volume":"20","author":"SM Bentzen","year":"1991","unstructured":"Bentzen SM, Johansen LV, Overgaard J, Thames HD: Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Rad Onc Bio Phys 1991, 20: 1197-1206. 10.1016\/0360-3016(91)90228-V","journal-title":"Int J Rad Onc Bio Phys"},{"key":"697_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/0360-3016(95)00261-V","volume":"32","author":"AC Begg","year":"1995","unstructured":"Begg AC: The clinical status of T\n                    pot\n                   as a predictor? or why no tempest in the T\n                    pot\n                  . Int J Rad Onc Bio Phys 1995, 32: 1539-1541. 10.1016\/0360-3016(95)00261-V","journal-title":"Int J Rad Onc Bio Phys"},{"issue":"1","key":"697_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-4682-9-23","volume":"9","author":"P Pedicini","year":"2012","unstructured":"Pedicini P, Caivano R, Jereczek-Fossa BA, et al.: Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors. Theor Biol Med Model 2012,9(1):23. 19 10.1186\/1742-4682-9-23","journal-title":"Theor Biol Med Model"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-7-143\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:16:29Z","timestamp":1548202589000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,24]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-143","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,24]]},"article-number":"143"}}